Impact of ultra-processed foods on rheumatic diseases
Official title: Impact of Ultra-processed Foods in a Population of Patients With Chronic Rheumatic Diseases (Rheumatoid Arthritis, Spondyloarthritis, Osteoarthritis).
Run by Hospices Civils de Lyon · NCT06776965 · Data updated 2026-11-12
This study looks at how eating ultra-processed foods might affect people with chronic rheumatic diseases like rheumatoid arthritis and osteoarthritis to see if it makes their symptoms worse.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Lyon) |
| Status | Recruiting |
| Started | March 31, 2025 |
| Main results expected | March 31, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | April 11, 2025 |
| Trial ID | NCT06776965 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with a diagnosis of chronic rheumatic diseases.
✕Probably not a fit
Patients with two simultaneous rheumatic diseases or those under judicial protection may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the consumption patterns of ultra-processed foods (UPF) among patients with chronic rheumatic diseases such as rheumatoid arthritis, spondyloarthritis, and osteoarthritis. It will assess the relationship between UPF consumption and disease activity using various evaluation tools, including dietary questionnaires and disease activity scores. The study seeks to understand whether UPF consumption is linked to increased risk or exacerbation of these conditions, potentially through mechanisms affecting gut microbiota and immune responses.
Why it matters
Potential benefit: If successful, this study could provide insights into dietary modifications that may help manage or reduce the severity of rheumatic diseases.
How similar studies have gone: While the specific relationship between UPF and rheumatic diseases is not extensively studied, there is emerging evidence linking diet to inflammatory conditions, suggesting potential for meaningful findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * chronic rheumatic disease (Rheumatoid arthritis, spondyloarthritis, osteoarthritis) * ability to perform questionnaires Exclusion Criteria: * Judicial protection measure * Refusal to participate in the study * Suffering from 2 rheumatic disease simultaneously
Where it's running
-
Edouard Herriot Hospital
Lyon, France Recruiting
Study contacts
- Principal investigator: Maxime AUROUX, MD — Hôpital Edouard Herriot
- Study coordinator: Maxime AUROUX, MD
- Email: Maxime.auroux@chu-lyon.fr
- Phone: +33472117479
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
EMPHASYS cup placement with VELYS non-invasive hip navigation in total hip replacement
This research tests whether using the VELYS non-invasive hip navigation system helps surgeons place the EMPHASYS acetabular cup more accurately during total hip replacement for people with osteoarthritis or other hip conditions.
-
Biobank for patients with inflammatory chronic diseases and osteoporosis
This study is creating a biobank to collect samples from patients with chronic inflammatory diseases and osteoporosis to see if they can find markers that help doctors choose better treatments.
-
Characterizing gut bacteria in people with spondyloarthritis or rheumatoid arthritis
This project will test whether the mix of gut bacteria differs between adults with spondyloarthritis or rheumatoid arthritis and healthy volunteers by analyzing stool and blood samples.
-
GenAI-assisted RA bone erosion risk and DMARD choice
This study tests whether GenAI-based decision support can help doctors assess rheumatoid arthritis bone erosion risk and pick DMARDs for newly diagnosed inpatients.
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Early wear of a Vitamin E-infused liner in a dual-mobility hip replacement
This study tests whether a Vitamin E-infused liner in a dual-mobility hip implant wears as little as a conventional liner over two years in adults needing hip replacement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.